
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The etiology of rheumatoid arthritis
Hans Ulrich Scherer, Thomas Häupl, Gerd R Burmester
Journal of Autoimmunity (2020) Vol. 110, pp. 102400-102400
Open Access | Times Cited: 632
Hans Ulrich Scherer, Thomas Häupl, Gerd R Burmester
Journal of Autoimmunity (2020) Vol. 110, pp. 102400-102400
Open Access | Times Cited: 632
Showing 1-25 of 632 citing articles:
Management of Rheumatoid Arthritis: An Overview
Andrei-Flavius Radu, Simona Bungău
Cells (2021) Vol. 10, Iss. 11, pp. 2857-2857
Open Access | Times Cited: 613
Andrei-Flavius Radu, Simona Bungău
Cells (2021) Vol. 10, Iss. 11, pp. 2857-2857
Open Access | Times Cited: 613
Epstein-Barr Virus and Systemic Autoimmune Diseases
Gunnar Houen, Nicole Hartwig Trier
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 268
Gunnar Houen, Nicole Hartwig Trier
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 268
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Qian Ding, Wei Hu, Ran Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 203
Qian Ding, Wei Hu, Ran Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 203
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 195
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 195
JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future
Jacopo Angelini, Rossella Talotta, Rossana Roncato, et al.
Biomolecules (2020) Vol. 10, Iss. 7, pp. 1002-1002
Open Access | Times Cited: 148
Jacopo Angelini, Rossella Talotta, Rossana Roncato, et al.
Biomolecules (2020) Vol. 10, Iss. 7, pp. 1002-1002
Open Access | Times Cited: 148
The association between systemic immune-inflammation index and rheumatoid arthritis: evidence from NHANES 1999–2018
Bo Liu, Jie Wang, Yanyan Li, et al.
Arthritis Research & Therapy (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 148
Bo Liu, Jie Wang, Yanyan Li, et al.
Arthritis Research & Therapy (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 148
Effect of Ginger on Inflammatory Diseases
Pura Ballester, Begoña Cerdá, Raúl Arcusa, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7223-7223
Open Access | Times Cited: 107
Pura Ballester, Begoña Cerdá, Raúl Arcusa, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7223-7223
Open Access | Times Cited: 107
Targeted Therapy for Inflammatory Diseases with Mesenchymal Stem Cells and Their Derived Exosomes: From Basic to Clinics
Shuo Wang, Biyu Lei, E Zhang, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 1757-1781
Open Access | Times Cited: 98
Shuo Wang, Biyu Lei, E Zhang, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 1757-1781
Open Access | Times Cited: 98
miRNAs insights into rheumatoid arthritis: Favorable and detrimental aspects of key performers
Ahmed S. Doghish, Ahmed Ismail, Hesham A. El-Mahdy, et al.
Life Sciences (2022) Vol. 314, pp. 121321-121321
Closed Access | Times Cited: 71
Ahmed S. Doghish, Ahmed Ismail, Hesham A. El-Mahdy, et al.
Life Sciences (2022) Vol. 314, pp. 121321-121321
Closed Access | Times Cited: 71
Role of reactive oxygen species and mitochondrial damage in rheumatoid arthritis and targeted drugs
Weiyao Jing, Cui Liu, Su Chenghong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 62
Weiyao Jing, Cui Liu, Su Chenghong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 62
Short chain fatty acids, a possible treatment option for autoimmune diseases
Faezeh Golpour, Mehrsa Abbasi-Alaei, Fatemeh Babaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114763-114763
Open Access | Times Cited: 56
Faezeh Golpour, Mehrsa Abbasi-Alaei, Fatemeh Babaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114763-114763
Open Access | Times Cited: 56
Long non-coding RNAs and rheumatoid arthritis: Pathogenesis and clinical implications
Ola Elazazy, Heba M. Midan, Reem K. Shahin, et al.
Pathology - Research and Practice (2023) Vol. 246, pp. 154512-154512
Closed Access | Times Cited: 49
Ola Elazazy, Heba M. Midan, Reem K. Shahin, et al.
Pathology - Research and Practice (2023) Vol. 246, pp. 154512-154512
Closed Access | Times Cited: 49
A Brief Overview: Sex Differences in Prevalent Chronic Musculoskeletal Conditions
Demario S. Overstreet, Larissa J. Strath, Mackensie Jordan, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 5, pp. 4521-4521
Open Access | Times Cited: 47
Demario S. Overstreet, Larissa J. Strath, Mackensie Jordan, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 5, pp. 4521-4521
Open Access | Times Cited: 47
MHC Class II Presentation in Autoimmunity
Irina A. Ishina, Maria Yu. Zakharova, Inna N. Kurbatskaia, et al.
Cells (2023) Vol. 12, Iss. 2, pp. 314-314
Open Access | Times Cited: 42
Irina A. Ishina, Maria Yu. Zakharova, Inna N. Kurbatskaia, et al.
Cells (2023) Vol. 12, Iss. 2, pp. 314-314
Open Access | Times Cited: 42
Development of biomedical hydrogels for rheumatoid arthritis treatment
Mirza Muhammad Faran Ashraf Baig, Lee Ki Wong, Abdul Wasy Zia, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 1, pp. 100887-100887
Open Access | Times Cited: 16
Mirza Muhammad Faran Ashraf Baig, Lee Ki Wong, Abdul Wasy Zia, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 1, pp. 100887-100887
Open Access | Times Cited: 16
Understanding exosomes: Part 2—Emerging leaders in regenerative medicine
Richard J. Miron, Nathan E. Estrin, Anton Sculean, et al.
Periodontology 2000 (2024) Vol. 94, Iss. 1, pp. 257-414
Open Access | Times Cited: 16
Richard J. Miron, Nathan E. Estrin, Anton Sculean, et al.
Periodontology 2000 (2024) Vol. 94, Iss. 1, pp. 257-414
Open Access | Times Cited: 16
Tripterygium wilfordii: An inspiring resource for rheumatoid arthritis treatment
Yanqiong Zhang, Xia Mao, Weijie Li, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1337-1374
Closed Access | Times Cited: 135
Yanqiong Zhang, Xia Mao, Weijie Li, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1337-1374
Closed Access | Times Cited: 135
Periodontitis and rheumatoid arthritis: What have we learned about their connection and their treatment?
Jerián González‐Febles, Mariano Sanz
Periodontology 2000 (2021) Vol. 87, Iss. 1, pp. 181-203
Closed Access | Times Cited: 90
Jerián González‐Febles, Mariano Sanz
Periodontology 2000 (2021) Vol. 87, Iss. 1, pp. 181-203
Closed Access | Times Cited: 90
Preclinical Autoimmune Disease: a Comparison of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis and Type 1 Diabetes
Giulia Frazzei, Ronald van Vollenhoven, Brigit A. de Jong, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 64
Giulia Frazzei, Ronald van Vollenhoven, Brigit A. de Jong, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 64
From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis
J. Inciarte-Mundo, Beatriz Frade‐Sosa, Raimón Sanmartí
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 60
J. Inciarte-Mundo, Beatriz Frade‐Sosa, Raimón Sanmartí
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 60
Impact of the host response and osteoblast lineage cells on periodontal disease
Mi Zhou, Dana T. Graves
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 54
Mi Zhou, Dana T. Graves
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 54
Metabolomics in rheumatoid arthritis: Advances and review
Lingxia Xu, Cen Chang, Ping Jiang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50
Lingxia Xu, Cen Chang, Ping Jiang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50
Gut Dysbiosis and Fecal Microbiota Transplantation in Autoimmune Diseases
Paulína Belvončíková, Martin Marônek, Roman Gardlík
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10729-10729
Open Access | Times Cited: 46
Paulína Belvončíková, Martin Marônek, Roman Gardlík
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10729-10729
Open Access | Times Cited: 46
Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches
Ana Merino‐Vico, Giulia Frazzei, Jan Piet van Hamburg, et al.
European Journal of Immunology (2022) Vol. 53, Iss. 1
Open Access | Times Cited: 44
Ana Merino‐Vico, Giulia Frazzei, Jan Piet van Hamburg, et al.
European Journal of Immunology (2022) Vol. 53, Iss. 1
Open Access | Times Cited: 44
Current Status, Issues and Future Prospects of Personalized Medicine for Each Disease
Yuichi Yamamoto, Norihiro Kanayama, Yusuke Nakayama, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 3, pp. 444-444
Open Access | Times Cited: 43
Yuichi Yamamoto, Norihiro Kanayama, Yusuke Nakayama, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 3, pp. 444-444
Open Access | Times Cited: 43